当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析

智飞生物

(300122)

  

流通市值:309.73亿  总市值:524.24亿
流通股本:14.14亿   总股本:23.94亿

智飞生物(300122)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-5.97亿元,每股收益-0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益3023364.38万元,未分配利润2664295.92万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产4593727.32万元,负债1570362.94万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入4,919,216,833.152,374,498,616.1126,069,711,361.4422,786,306,742.43
营业总成本5,343,407,811.42,434,178,574.4723,192,418,166.6419,685,884,775.99
其他经营收益
营业利润-783,202,114.39-332,730,093.072,263,812,276.882,484,710,924.74
利润总额-784,265,755.31-333,117,143.242,253,691,570.882,477,954,662.48
净利润-597,095,590.86-305,140,593.282,018,478,513.912,150,622,937.94
每股收益
其他综合收益----
综合收益总额-597,095,590.86-305,140,593.282,018,478,513.912,150,622,937.94
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计37,147,358,079.0939,675,364,495.941,292,988,542.9345,458,060,346.55
非流动资产:
非流动资产合计8,789,915,160.468,664,955,347.558,616,625,292.478,251,514,241.9
资产总计45,937,273,239.5548,340,319,843.4549,909,613,835.453,709,574,588.45
流动负债:
流动负债合计15,169,801,793.7317,263,558,980.8918,441,126,104.3721,649,036,529.03
非流动负债:
非流动负债合计533,827,628.58551,162,047.74637,748,322.93618,896,277.89
负债合计15,703,629,422.3117,814,721,028.6319,078,874,427.322,267,932,806.92
所有者权益(或股东权益):
归属于母公司股东权益合计30,233,643,817.2430,525,598,814.8230,830,739,408.131,441,641,781.53
股东权益合计30,233,643,817.2430,525,598,814.8230,830,739,408.131,441,641,781.53
负债和股东权益合计45,937,273,239.5548,340,319,843.4549,909,613,835.453,709,574,588.45
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计7,548,643,715.423,846,455,890.3237,072,888,214.4528,515,112,725.1
经营活动现金流出小计5,984,269,026.933,542,300,800.5541,486,877,529.6531,580,081,449.83
经营活动产生的现金流量净额1,564,374,688.49304,155,089.77-4,413,989,315.2-3,064,968,724.73
投资活动产生的现金流量:
投资活动现金流入小计10,817,645.610,364,945.64,759,655.974,655,142.17
投资活动现金流出小计259,397,490.09149,039,120.66930,343,067.65700,478,076.61
投资活动产生的现金流量净额-248,579,844.49-138,674,175.06-925,583,411.68-695,822,934.44
筹资活动产生的现金流量:
筹资活动现金流入小计7,724,634,474.265,944,474,956.7214,739,339,451.6410,265,312,326.46
筹资活动现金流出小计9,174,961,023.495,742,030,644.913,041,452,581.479,580,673,016.8
筹资活动产生的现金流量净额-1,450,326,549.23202,444,311.821,697,886,870.17684,639,309.66
汇率变动对现金及现金等价物的影响-443,332.42-122,611.31,252,023.78-801,413.27
现金及现金等价物净增加额-134,975,037.65367,802,615.23-3,640,433,832.93-3,076,953,762.78
期末现金及现金等价物余额2,563,881,364.333,066,659,017.212,698,856,401.983,262,336,472.13
补充资料:
现金及现金等价物的净增加额-134,975,037.65--3,640,433,832.93-
TOP↑